Tag: SynCardia Systems

  • From Proven to Pioneering: SynCardia’s Next Leap in Artificial Heart Technology

    From Proven to Pioneering: SynCardia’s Next Leap in Artificial Heart Technology

    Phoenix, AZ (November 12, 2025) – Tucson-based SynCardia Systems, LLC, the manufacturer of the SynCardia Total Artificial Heart, is a wholly owned subsidiary of Picard Medical, Inc. Picard Medical became a publicly traded company on August 29, 2025, and completed its Initial Public Offering (IPO) on September 2, 2025, raising approximately $19.5 million in gross…

  • Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering

    Picard Medical, Inc. Announces Pricing of $17 Million Initial Public Offering

    TUCSON, ARIZONA, August 28, 2025 — Picard Medical, Inc. (“Picard” or the “Company”), a medical technology company that manufactures and sells the only total artificial heart (the “SynCardia Total Artificial Heart”, or “STAH”) approved by the U.S. Food and Drug Administration (“FDA”), and Health Canada, today announced the pricing of its initial public offering (the…